| Literature DB >> 30542511 |
Alborz Adeli1, Katharina Hess2, Christian Mawrin3, Eileen Maria Susanne Streckert4, Walter Stummer4, Werner Paulus2, André Kemmling1, Markus Holling4, Walter Heindel1, Rene Schmidt5, Dorothee Cäcilia Spille5, Peter B Sporns1, Benjamin Brokinkel4.
Abstract
Brain invasion (BI) in meningiomas impacts WHO grading and therefore adjuvant treatment. However, BI is rare and neurosurgical sampling and neuropathological analyses are not standardised. Moreover, associations with imaging findings are sparsely known. Associations between BI and findings on preoperative MRI were investigated in 617 meningioma patients. BI was strongly correlated with other high-grade criteria (p<.001). Presence of a contrast enhancing tumour capsule, disruption of the arachnoid layer, intratumoural calcifications and T2-intensity were not related to high-grade histology or BI (p>.05, each). High-grade histology (p=.033) but not BI (p=.354) was associated with tumour location. Irregular tumour shape (OR: 3.33, 95%CI 1.33-8.30; p=.007), heterogeneous contrast enhancement (OR: 2.82, 95%CI 1.19-6.70; p=.015) and peritumoural edema (OR: 1.005 per ccm, 95%CI 1.001-1.008); p=.011) were associated with BI. Multivariable analyses identified only increasing edema volume (OR: 1.005 per ccm, 95%CI 1.002-1.009; p=.010) as a predictor for BI, independent of other histopathological high-grade criteria. We finally provide a new model to estimate the risk of BI using routine preoperative MRI. Several imaging characteristics were identified as predictors for BI. Consideration in clinical routine can increase the accuracy of the detection in neuropathological analyses.Entities:
Keywords: brain invasion; grading; magnetic resonance imaging; meningioma; radiology
Year: 2018 PMID: 30542511 PMCID: PMC6267603 DOI: 10.18632/oncotarget.26313
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Summarization of radiological and histopathological data of patients with primary diagnosed and recurrent meningioma
| Variable | Available data (N, n%) | Frequency (N, n%) |
|---|---|---|
| 617 (100%) | ||
| Convexity | 215 (35%) | |
| Falx/parasagittal | 85 (14%) | |
| Skull base | 271 (44%) | |
| Posterior fossa | 41 (7%) | |
| Intraventricular | 5 (1%) | |
| Tumour volume (median, range) | 554 (90%) | 12.71 ccm (0.02-356.94 ccm) |
| Edema volume (median, range) | 529 (86%) | 0.00 ccm (0.00-739.28 ccm) |
| 540 (88%) | ||
| Hypointense | 294 (48%) | |
| Isointense | 19 (3%) | |
| Hyperintense | 227 (37%) | |
| Archnoid layer disrupted/absent | 531 (86%) | 296 (48%) |
| Heterogeneous T1 contrast enhancement | 617 (100%) | 262 (43%) |
| Tumour shape irregular | 558 (90%) | 225 (37%) |
| Tumour calcifications | 554 (88%) | 115 (19%) |
| Capsular contrast enhancement | 523 (85%) | 160 (26%) |
| 617 (100%) | ||
| WHO grade I | 557 (90%) | |
| WHO grade II | 57 (9%) | |
| WHO grade III | 3 (1%) | |
| 617 (100%) | ||
| Present | 24 (4%) |
The left column delineates the rate of available data, the right column shows the frequency of the corresponding variable and the median/range of the tumour and PTBE volumes.
Figure 1Boxpots visualizing the degree of association between peritumoural edema (PTBE) volume and histopathological findings
High-grade histology was associated with increased PTBE volume (left, p=.002) and PTBE volumes were larger in invasive than in non-invasive meningiomas (p<.001, right). However, no association was found between edema volume and other histopathological grading criteria (p=.117). The boxes indicate upper and lower 25% quartile, the whiskers the minimum/maximum value within 1.5 IQR of the lower/upper quartile, the dots the outliers, the asterisks the extreme values, and the heavy horizontal line indicates the median (ccm=cubic centimeter, *high-grade=grade II and III meningiomas.).
Association between brain invasion and clinical and radiological variables in uni- and multivariable logistic regression
| Variable | Univariable analysis: OR (95% CI) | p-value | Multivariable analysis: OR (95% CI) | p-value | ||
|---|---|---|---|---|---|---|
| Gender: Male vs female (ref.) | 2.20 (0.96 to 5.00) | p=.067 | 2.45 (0.81 to 7.40) | p=.113 | ||
| Age at surgery (in years) | 1.022 (0.992 to 1.052) | p=.146 | N/S | p=.149 | ||
| Tumour location: Convexity/ falcine vs other (ref.) | 1.57 (0.60 to 4.13) | p=.354 | N/S | p=.490 | ||
| Tumour volume (in ccm) | 1.003 (0.993 to 1.013) | p=.588 | N/S | p=.791 | ||
| Edema volume | 1.005 (1.001 to 1.008) | p=.011 | 1.005 (1.002 to 1.009) | p=.010 | ||
| Intensity on T2-weighted MRI | p=.310 | N/S | p=.084 | |||
| Isointense vs Hyperintense (ref.) | 3.70 (0.71 to 19.20) | |||||
| Hypointense vs Hyperintense (ref.) | 1.57 (0.62 to 3.96) | |||||
| Arachoid layer: Interrupted vs Intact (ref.) | 1.06 (0.44 to 2.56) | p=.895 | N/S | p=.186 | ||
| Contrast enhancement: Heterogeneous vs Homogeneous (ref.) | 2.82 (1.19 to 6.70) | p=.015 | N/S | p=.084 | ||
| Tumour shape: Irregular vs Regular (ref.) | 3.33 (1.33 to 8.30) | p=.007 | N/S | p=.121 | ||
| Tumour calcifications: Present vs Absent (ref.) | 0.87 (0.29 to 2.65) | p=.808 | N/S | p=.827 | ||
| Capsular contrast enhancement: Present vs Absent (ref.) | 0.97 (0.37 to 2.58) | p=.372 | N/S | p=.861 | ||
Adjusted for gender, PTBE volume was identified as the only independent predictor for brain invasive growth (Abbreviations: N/S: not specified because not selected in multivariable analysis, OR: Odds ratio, CI: Confidence interval, p: p-value of likelihood ratio / score test for selected / non-selected variables, ref.: reference group).
Figure 2Prediction of brain invasion using findings on preoperative MRI
Predicted probability of brain invasive growth depending on PTBE volume in females (A) and males (B) according to the final multivariable model (Table 2).
Figure 3Illustrative examples of the analyzed MRI variables
In (A), axial T2-weighted MRI shows cerebrospinal fluid at the brain/meningioma border (arrow), indicating a distinct tumour surface with an intact arachnoid layer. In (B and C), sagittal T1-weighted images show a contrast-enhancing tumour capsule (B, arrow), a heterogeneous gadolinium enhancement (C) and an irregular tumour shape with mushroom-like growth (C).